Advertisement

Systemic Contraception at Primary Health Care Level and Who should Apply Them

  • R. A. Apelo

Abstract

The term “systemic contraception” in this paper refers only to that induced by oral pills and by long- acting progestin injectables because they are the ones more commonly available in most countries. Other contraceptives which make use of steroids for contraception control like vaginal rings, the implants (both the biodegradable and non-biodegradable), the nasal sprays and the male pills are still investigated and therefore are not included in the discussion.

Keywords

Oral Contraceptive Medroxyprogesterone Acetate Vaginal Ring Oral Contraceptive User Breast Cyst 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Apelo R et al (1974): Acceptability of injectable contraception in the Philippines. IPPF Medical Bulletin, ( April).Google Scholar
  2. Apelo R, dela Cruz J (1973): Depoprovera, an effective contraceptive agent. J Phil Med Assoc, 49: 179 – 196.Google Scholar
  3. Back DJ, Breckenridge AM (1978): Drug interactions with oral contraceptive. IPPF Medical Bulletin, 12 (4).Google Scholar
  4. Back DJ, Breckenridge AM et al (1980): The effect of rifampicin and the pharmacokinetics of ethinyl estradiol in women. Contraception, 21 (2).Google Scholar
  5. Back DJ et al (1979): Drug — drug interactions, studies with oral contraceptive steriod. In: Drug Assessment, Criteria and Method, Elsevier/Northhill Biomedical Press, pp. 185 – 206.Google Scholar
  6. Boyce JG, Lu T, Nelson JH Jr, Fruchter RG (1977): Oral contraceptives and cervical carcinoma. Am J Obstet Gyn, 128: 761 – 766.Google Scholar
  7. Briggs M (1978): Rationale of dosages and ratios of oral contraceptive steroids in combined products. Meeting of the Steering Committee, Task Force on Oral Contra¬ceptives, World Health Organization, Singapore.Google Scholar
  8. Edmunson HA, Henderson B, Benton B (1976): Liver cell adenomas associated with use of oral contraceptives. New Eng J Med 294: 470 – 472.CrossRefGoogle Scholar
  9. Egren R, Strutevart FM (1976): Potencies of oral contraceptives. Am J Obstet Gyn 125: (8).Google Scholar
  10. Fräser I, Weisberg E (1981): A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. Med J Australia 1: (1).Google Scholar
  11. Goldzieher JW, Dozier TS (1973): Oral contraceptive and thromboembolism. A reassessment. Am J Obstet Gyn, 123: 878–914.Google Scholar
  12. Kay CR (1980): The happiness pill. J Royal Col Gen Pract, (Jan).Google Scholar
  13. Mann JL, Doll T, Thorogood M, Vessey MP, Waters WE (1976): Risk factors for myocardial infarction in young women. Brit J Prev Soc Med, 30: 94 – 100.Google Scholar
  14. Nora AH, Nora JJ (1978): Maternal exposure to exogenous progestogen/estrogen as a potential cause of birth defects. Advances in Planned Parenthood, 12: 156 – 169.PubMedGoogle Scholar
  15. Population Report (1979): Oral contraceptives — Update on usage, safety and side effects. Population Report, A(5).Google Scholar
  16. World Health Organizatin (1979): The effect of female sex hormones on fetal development and infant health. Report of the WHO Scientific Group, ( December).Google Scholar
  17. Ministry of Health, Philippines (1980): Sarikaya Manual. National Family Planning Office.Google Scholar
  18. Shapiro S ( 1979 ): Oral contraceptive use in relation to myocardial infarction. Lancet, ( April ).Google Scholar
  19. Poller L (1978): Oral contraceptives, blood clotting and thrombosis. Brit Med Bull, 34: 151 – 156.PubMedGoogle Scholar
  20. Report (1978): The Special Advisory Committee on Reproductive Physiology report to the Health Protection Branch. (March)Google Scholar
  21. Royal College of General Practitioners (1974): Oral contraception and health. An interim report from the Oral Contraception Study of the Royal College of General Practitioners. Pitman, New York.Google Scholar
  22. Royal College of General Practitioners (1977): Oral contraceptive study. Mortality among oral contraceptive users. Lancet, 2: 727 – 731.Google Scholar
  23. Steel JM, Duncan LPJ (1978): The effect of oral contraceptive on insulin requirements in diabetes. Brit J Family Planning, 3: 77.Google Scholar
  24. Stern EB (1977): Steriod contraceptive use and cervical dysplasia. Increased risk of progression. Science, 196: 1460 – 1462.PubMedCrossRefGoogle Scholar
  25. Vessey MP, Mann JI (1978): Female sex hormones and thrombosis. Brit Med Bull, 34: 157 – 162.PubMedGoogle Scholar
  26. Vessey MP, Kay Clifford R, Wingrave S (1979): Oral contraceptives and diabetes mellitus. Brit Med J, (Jan).Google Scholar
  27. WHO (1977): Multinational comparative clnical evaluation of two long acting injectable contraceptive steriods: norethisterone enanthate and medroxyprogesterone acetate. Conception, 15: (15)Google Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • R. A. Apelo
    • 1
  1. 1.College of MedicineUniversity of the Philippines and the National Family Planning OfficeManilaPhilippines

Personalised recommendations